WNK2 and colorectal carcinoma: The mitogen-activated protein kinase (MAPK) pathway is a major driver of CRC development and therapy response; however, the distribution and prognostic value of MAPK alterations across distinct patient subgroups remain unclear.<h4>Methods</h4>We analyzed 2515 CRC tumors with harmonized demographic, clinical, genomic, and treatment metadata.